A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and ...
Flavored nicotine pouches called Zyn could soon be legally advertised as a lower-risk option for adults who smoke, as federal ...
Soon after the FDA’s guidance release, two other major AI announcements also hit the news: Utah began a first-in-the-nation pilot with Doctronic for autonomous AI prescription refills, and OpenAI ...
Americans who smoke may soon be hearing a lot more about Zyn, the flavored nicotine pouches that have generated billions in sales while going viral on social media.
A new review suggests that the FDA usually followed the science, not politics, when making decisions about the abortion pill mifepristone.
The Trump administration's elevation of a vaccine skeptic to lead a high-profile office within the Food and Drug Administration is raising alarm among multiple senior FDA officials, who told CBS News ...
PROVIDENCE, R.I., Dec. 8, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators ...
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals to develop two agentic AI assistants for ...
The FDA has taken a cautious and scientific evidence-based approach to regulating mifepristone (Mifeprex) over the years, contrary to what the Trump administration has alleged, an analysis of agency ...
WASHINGTON (AP) — The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to lead the agency's drug center, replacing the former drug director who was recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results